ADORA2A Antagonist Antibodies for Immuno-Oncology, Primed for Development
Tap into the next generation of immune checkpoint inhibition for broad cancer indications
Twist Biosciences
GLP-1R Agonist Antibodies for Weight Management, Primed for Clinical Development
Antibodies with best-in-class potential for addressing the growing need in obesity and diabetes
Out-Licensing | Twist Bioscience
Navigating The Journey from Bench to Bedside
Therapeutic antibodies continue to change how we treat human diseases. But antibody discovery and optimization present several challenges and the overwhelming majority of leads that enter pre-clinical testing will fail to navigate the twists and turns on the path to market. Even highly potent and specific candidates can have suboptimal developability profiles and face downstream aggregation, stability, formulation, or manufacturing problems.
Usin
Writing the Future of Biologics | Twist Biopharma Brochure
Antibody therapeutics are an important class of drugs that have changed the
medical landscape and the treatment of autoimmune, metabolic, neurologic,
infectious diseases, cancer, and more. Discovery and optimization efforts in
this space are expanding rapidly and there is significant potential for treating
diseases for which no current therapies exist.
Antibody Discovery and Development ebook
You’re about to embark on a journey of discovery. And like all journeys that are worthwhile, it’s far from linear. The process of antibody discovery and development into a clinical candidate is one full of twists, turns, roundabouts and offshoots, yet one that an increasing number of researchers and companies, both small and large, have successfully navigated.
